Ook interessant
Gilteritinib post TKI (2022)
Publication
Clinical outcomes in patients with relapsed/refractory FLT3- mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib.
Find out moreTear-off pad on AML with FLT3 mutation
This tear-off pad has been created to provide clear explanations about FLT3-mutated AML for patients.
Find out more
AML ELN Guidance (2022)
Publication
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
MAT-BE-XOS-2023-00021 - November 2023